Company / Operating Cash Flow
Teladoc Health, Inc. Operating Cash Flow History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow
$294.4M
FY2025
5-year range
$189.3M / $350.0M
FY2021-FY2025
Trend
+0.2%
vs FY2024
Sector context
#67 of 158
Health Care
What the data says
At $294M, Teladoc Health, Inc.'s operating cash flow ranks #67 of 158 in the Health Care sector. Operating Cash Flow has fluctuated over the past 10 years, ranging from -$54M in FY2020 to $350M in FY2023.
Based on SEC 10-K filings.
$294M in FY2025 with a 3-year CAGR of +15.9%.
Declined from $350M to $294M over the past 2 years.
Health Care sector context is included.
Operating Cash Flow over time
Growth rates
- 3-Year CAGR
- +15.9%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#67 of 158 in Health CareTop 42% of 158This company $294.4M Sector average $1.0B
▼
-71.5% below sector average
Key checks
Key Insights
- 3-year CAGR of +15.9%, indicating consistent growth.
- In FY2025, operating cash flow increased 0.2% year-over-year.
- Ranks #67 out of 158 companies in the Health Care sector.
- Peak operating cash flow was recorded in FY2023.
Company context
Key Data Points
- Altman Z-Score -3.70 (distress zone, below 1.8 threshold)
- Negative profit margin: -8.8%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $294.4M | +0.2% |
| FY2024 | $293.7M | -16.1% |
| FY2023 | $350.0M | +84.9% |
| FY2022 | $189.3M | -2.4% |
| FY2021 | $194.0M | +462.5% |
| FY2020 | -$53.5M | -279.2% |
| FY2019 | $29.9M | +714.6% |
| FY2018 | -$4.9M | +85.9% |
| FY2017 | -$34.4M | +33.6% |
| FY2016 | -$51.9M | -9.9% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026